Literature DB >> 19555735

Hepcidin, the iron watcher.

Lydie Viatte1, Sophie Vaulont.   

Abstract

Hepcidin, a peptide hormone produced by the liver, constitutes the master regulator of iron homeostasis in mammals allowing iron adaptation according to the body iron needs. In recent years there has been important breakthrough in our knowledge of hepcidin regulation that has also implications for understanding the physiopathology of human iron disorders. Different aspects of hepcidin regulation will be considered in this review, including regulation by the iron status and the BMP6/HJV/SMAD pathway. Hepcidin dysregulation in iron disorders will be also discussed. Although much can already be accomplished for treating iron disorders using the knowledge that has currently been developed, additional issues will be challenging for the coming years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555735     DOI: 10.1016/j.biochi.2009.06.012

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  32 in total

1.  Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages.

Authors:  Carole Beaumont
Journal:  Haematologica       Date:  2010-08       Impact factor: 9.941

2.  17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site.

Authors:  Qing Yang; Jinlong Jian; Stuart Katz; Steven B Abramson; Xi Huang
Journal:  Endocrinology       Date:  2012-04-25       Impact factor: 4.736

3.  PGC-1α regulates hepatic hepcidin expression and iron homeostasis in response to inflammation.

Authors:  Jinchun Qian; Siyu Chen; Yueyue Huang; Xiaoli Shi; Chang Liu
Journal:  Mol Endocrinol       Date:  2013-02-25

4.  Bmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degeneration.

Authors:  Majda Hadziahmetovic; Ying Song; Natalie Wolkow; Jared Iacovelli; Leon Kautz; Marie-Paule Roth; Joshua L Dunaief
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

5.  Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice.

Authors:  Majda Hadziahmetovic; Ying Song; Padmavathi Ponnuru; Jared Iacovelli; Allan Hunter; Nadine Haddad; John Beard; James R Connor; Sophie Vaulont; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

Review 6.  Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Authors:  J Rochette; G Le Gac; K Lassoued; C Férec; K J H Robson
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

7.  Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6.

Authors:  Anne Lenoir; Jean-Christophe Deschemin; Léon Kautz; Andrew J Ramsay; Marie-Paule Roth; Carlos Lopez-Otin; Sophie Vaulont; Gaël Nicolas
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

8.  Iron: an emerging factor in colorectal carcinogenesis.

Authors:  Anita C G Chua; Borut Klopcic; Ian C Lawrance; John K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

9.  Polysaccharide isolated from Angelica sinensis inhibits hepcidin expression in rats with iron deficiency anemia.

Authors:  Jin-Yu Liu; Yu Zhang; Ru-Xu You; Fang Zeng; Dan Guo; Kai-Ping Wang
Journal:  J Med Food       Date:  2012-09-17       Impact factor: 2.786

10.  Increased risk of iron deficiency and reduced iron absorption but no difference in zinc, vitamin A or B-vitamin status in obese women in India.

Authors:  Isabelle Herter-Aeberli; Prashanth Thankachan; Beena Bose; Anura V Kurpad
Journal:  Eur J Nutr       Date:  2015-10-10       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.